Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
ICL surgery is typically FDA-approved for ages 21-45 with stable prescriptions; candidacy requires comprehensive anatomical evaluation including anterior chamber depth and endothelial cell count.
The ICL is an additive, reversible procedure suitable for high myopia and thin corneas where LASIK may not be recommended.
Preoperative evaluation typically includes dilated retinal exam, lens sizing measurements, and verification of adequate anterior chamber depth (≥3.00mm).
Contact lenses must be discontinued before surgery (typically 1-4 weeks depending on lens type) to allow corneas to return to baseline shape.
Educational information only
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
What Is the ICL and Who Is It For?
The EVO ICL (Implantable Collamer Lens) represents a fundamentally different approach to vision correction compared to corneal procedures like LASIK. Rather than reshaping the cornea with a laser, the ICL is a thin, prescription lens that is implanted in front of the natural lens, working with the eye's existing optical system to reduce dependence on glasses or contact lenses S1.
This distinction matters because the ICL is classified as an additive procedure—the natural lens remains in place, and the implant is simply positioned to correct refractive error. This has several implications for candidacy and outcomes that differentiate ICL from laser-based alternatives S2.
How the EVO ICL Works
The EVO ICL is made from Collamer, a proprietary material that is biocompatible with the eye's internal environment. The lens is inserted through a small incision (typically 2.8-3.0mm) and positioned in the space between the iris and the natural lens. This placement allows light to focus properly on the retina without altering corneal tissue S1.
A key feature of the EVO model is the central hole design, which allows for natural fluid circulation and reduces the need for a peripheral iridotomy (a separate laser procedure required with older ICL models) S2.
ICL vs. LASIK: Key Differences
Understanding the procedural differences helps clarify why some patients may be better candidates for ICL:
Feature
ICL
LASIK
Procedure Type
Additive (lens implanted)
Subtractive (cornea reshaped)
Reversibility
Reversible—lens can be removed
Generally permanent corneal change
Best For
High myopia (-3D to -20D), thin corneas
Low to moderate myopia, adequate corneal thickness
Dry Eye Impact
Minimal effect on tear production
May exacerbate dry eye symptoms
Visual Quality
May offer superior night vision for some
Dependent on ablation precision
The ICL may be particularly appropriate for patients with high myopia who exceed the treatable range for LASIK, or those with thin corneas that would not support adequate laser ablation S3.
Core Candidacy Requirements
Not every patient seeking vision correction qualifies for ICL surgery. The FDA-approved indications and anatomical requirements establish a framework that surgeons use to evaluate candidacy S2.
Age and Prescription Stability
The FDA label specifies that patients must be between 21 and 45 years of age at the time of implantation S2. This age range reflects the clinical evidence base and the physiological characteristics associated with stable vision correction outcomes.
Beyond age, the prescription must demonstrate stability within 0.5 diopters for at least one year prior to surgery S3. This requirement exists because implanting a lens for an unstable prescription may result in undercorrection or overcorrection as the eye's refractive error continues to change.
Anatomical Requirements
The eye's internal anatomy must accommodate the implant safely. The anterior chamber depth—the distance from the cornea's inner surface to the natural lens—must measure at least 3.00 millimeters S2. This space is essential to ensure adequate clearance between the ICL and the natural lens, preventing mechanical contact that could affect lens function or eye health.
Additionally, the endothelial cell density must meet minimum thresholds to ensure the cornea remains clear and healthy over time. The specific threshold varies by age and individual risk factors, which is why a comprehensive cell count analysis is required during evaluation S1.
Refractive Limits
The FDA-approved refractive range for EVO ICL covers myopia from -3.0 to -20.0 dioptersS2. For patients with astigmatism, toric ICL models can correct 1.0 to 4.0 diopters of cylinder S3.
Conditions That May Affect Candidacy
Certain anatomical findings or health conditions may preclude ICL surgery or require additional consideration before proceeding.
Absolute Contraindications
The following conditions typically disqualify patients from ICL candidacy S2:
Anterior chamber depth less than 3.00mm — insufficient space for safe implant placement
When meeting with a potential surgeon, consider asking S3:
What is your ICL certification status and how many procedures have you performed?
What is your rate of vault-related complications requiring revision?
How do you handle cases where the initial vault measurement is suboptimal?
What follow-up schedule do you recommend for international patients?
Surgeon Verification
Before committing to surgery, verify your surgeon's credentials and experience. ICL implantation requires specific manufacturer certification. Consider reviewing our eye surgeons to understand what qualifications to look for in a provider.
How to Prepare for Surgery
Proper preparation helps ensure accurate measurements and reduces procedural risk.
Before Surgery: Contact Lenses and Medications
Contact lens wear must be discontinued before preoperative measurements and surgery S3:
Soft contact lenses: discontinue at least 1 week before evaluation
Toric or rigid gas permeable lenses: discontinue at least 2-4 weeks before evaluation
This waiting period allows the cornea to return to its natural shape, ensuring accurate measurements for lens sizing.
Certain medications and supplements may need to be paused:
Blood thinners — may be discontinued under physician guidance to reduce bleeding risk
Anti-inflammatory medications — typically stopped 5-7 days before surgery
Some supplements — fish oil, vitamin E, and others may increase bleeding risk
Always discuss your complete medication list with your surgical team.
Arrange for transportation — vision will be impaired immediately after the procedure
Avoid eye makeup, lotions, and perfumes
Eat a light meal if local anesthesia is planned
Bring prescribed eye drops and any required documentation
Understanding Risks and Complications
While ICL surgery has a favorable safety profile when performed on appropriate candidates, understanding potential risks supports informed decision-making.
Common Side Effects
Some patients experience temporary effects following ICL implantation S1:
Glare or halos — particularly noticeable in low-light conditions during initial healing
Dry eye symptoms — typically milder than with LASIK but may occur
Elevation in intraocular pressure — managed with medications in the immediate postoperative period
When Revision May Be Needed
The vault—the space between the ICL and the natural lens—requires precise measurement. Optimal vault is approximately 250-750 micronsS2. Vault that is too high or too low may necessitate revision:
Low vault — may increase cataract risk over time
High vault — may affect angle structures and drainage
Some patients may require lens repositioning or exchange if vault measurements fall outside the optimal range after implantation. This underscores the importance of choosing an experienced surgeon who can accurately predict sizing requirements.
Individual Assessment Required
Vault measurements require in-person clinical assessment. This checklist cannot replace a comprehensive eye examination with appropriate diagnostic imaging. Individual anatomy varies significantly, and only a qualified eye surgeon can determine whether ICL is appropriate for your specific situation.
Recovery Timeline
Recovery following ICL surgery is generally rapid, though individual experiences vary S1:
Day 1: Vision typically improves significantly; some blur and mild discomfort are common
Week 1: Most daily activities can resume; eye drops are required
[ ] Protect eyes from water exposure per surgeon instructions
[ ] Maintain prescribed drop schedule
Travel Planning
If you are considering ICL surgery in Istanbul, coordinate your travel dates to allow adequate time for preoperative evaluation and initial recovery before return travel. Our travel assistance team can help coordinate appointments and accommodations.
Next Steps
If you have reviewed the candidacy requirements and believe ICL may be appropriate for your vision correction needs, the next step is a comprehensive evaluation with a qualified surgeon.
Start Your Plan to arrange a consultation and discuss whether ICL surgery aligns with your visual goals and anatomical profile.
